MustGrow Biologics Corp. MGROF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -26.84% | -48.98% | 1,300.38% | -4.07% | -9.03% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -26.84% | -48.98% | 1,300.38% | -4.07% | -9.03% |
| Cost of Revenue | 173.59% | 486.78% | 561.77% | 418.66% | 198.20% |
| Gross Profit | 5,747.02% | -833.76% | -269.18% | -102.56% | -100.46% |
| SG&A Expenses | 19.29% | 13.33% | 19.89% | 9.54% | 2.12% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 38.81% | 46.71% | 45.75% | 27.64% | 8.07% |
| Operating Income | 11.27% | -13.88% | -15.45% | -2,811.21% | -6,459.52% |
| Income Before Tax | 3.39% | -22.20% | -37.42% | -2,271.69% | -1,017.60% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 3.39% | -22.20% | -37.42% | -2,271.69% | -1,017.60% |
| Earnings from Discontinued Operations | -42.32% | -127.90% | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 0.02% | -27.32% | -45.72% | -2,436.37% | -1,106.26% |
| EBIT | 11.27% | -13.88% | -15.45% | -2,811.21% | -6,459.52% |
| EBITDA | -133.73% | -444.08% | -- | -- | -- |
| EPS Basic | 10.00% | -15.69% | -37.63% | -3,822.73% | -1,178.69% |
| Normalized Basic EPS | 24.39% | 0.44% | -16.44% | -3,500.00% | -1,056.41% |
| EPS Diluted | 10.00% | -15.69% | -37.63% | -3,822.73% | -1,178.69% |
| Normalized Diluted EPS | 24.39% | 0.44% | -16.44% | -3,500.00% | -1,056.41% |
| Average Basic Shares Outstanding | 15.66% | 10.25% | 5.16% | 2.30% | 1.68% |
| Average Diluted Shares Outstanding | 15.66% | 10.25% | 5.16% | 2.30% | 1.68% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |